German company Complement Therapeutics, which has a research laboratory at Stevenage Bioscience Catalyst, reports that the ...

Medium-dose OCU410 met the 12-month primary endpoint, reducing GA lesion growth by 31% versus control (P < .05), with ...

Good morning, and welcome to Ocugen's Webcast to discuss the Top Line 12-month Results from Phase II ArMaDa Clinical Trial Evaluating OCU410 for Geographic Atrophy or GA Secondary to Dry Age-related ...

Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth (31%) versus control at 12 months (p< ...

Northwestern Medicine investigators have uncovered a missing link behind the harmful effects of autoantibodies linked to ...

Q16W dosing interval; Furthermore, nearly 60% of the participants held the potential to extend the dosing interval to Q20W.

AMID rising and volatile global oil prices, a lawmaker has urged Congress to pass a measure that seeks to institutionalize active transport by establishing a nationwide network of safe, ...

Other herbs, like basil and parsley, can support heart health if you don’t like cilantro. Among the many herbs used in ...

A gene therapy called AMT-130 appears to be the first treatment to slow the progression of Huntington’s disease, an inherited ...

Can smartphone data detect idiopathic pulmonary arterial hypertension earlier? New research suggests digital tools could transform screening. Read more.

Famed destination spa debuts new program exploring modern mindfulness and holistic healingSEDONA, Ariz., March 26, 2026 ...

US nuclear waste disposal company Deep Isolation Nuclear Inc announced that federally funded research has shown that deep ...